Chiral Gold Nanostructure Monolayers as SERS Substrates for Ultrasensitive Detection of Enantiomer Biomarkers of Alzheimer's Disease
Angewandte Chemie International Edition · 19.05.2025 · 64 (21)
DOI: 10.1002/anie.202502115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 18.03.2025. Verfasst von Changlong Hao und 5 weiteren Autor:innen. Beteiligte Einrichtung: International Joint Research Laboratory for Biointerface and Biodetection, State Key Lab of Food Science and Technology, School of Food Science and T…. Hauptthemen laut MEDLINE: Gold, Alzheimer Disease, Nanostructures, Metal Nanoparticles. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Themen: Demenz
Abstract (Originalsprache)
The early diagnosis of neurodegenerative diseases, such as Alzheimer's disease (AD), requires the identification of sensitive and specific biomarkers. Detecting chiral molecules at concentrations relevant to disease states remains challenging. Herein, a new type of chiral gold nanostructure induced by D‐/L‐cysteine–leucine dipeptides with a g ‐factor of 0.1 was successfully synthesized for enantiomer biomarker detection. To enhance the discrimination performance, the chiral gold nanostructures were assembled into D‐/L‐Au monolayers. As surface‐enhanced Raman scattering (SERS) substrates, the D‐/L‐Au monolayers simultaneously deliver molecular structural specificity and enantioselectivity within a single spectrum, which can be a versatile, label‐free chiral discrimination strategy for the detection of D‐/L‐kynurenine (Kyn). The mechanism was unveiled to involve high enantioselective adsorption energies between L‐ and D‐Kyn on the lattice plane (221), resulting in enantioselective sensing. The results showed that the L‐Au monolayer reached a limit of detection (LOD) of 3.7 n m for L‐Kyn, while the D‐Au monolayer reached an LOD of 3.6 nM for D‐Kyn. Notably, there was a significant difference in D‐Kyn levels between AD patients and healthy individuals in serum samples, a distinction not observed for L‐Kyn, which positioned D‐Kyn as a potential novel biomarker for clinical prediagnosis of AD patients, marking the first report of its kind worldwide. This study provides a robust tool for advancing biomedical science and clinical diagnostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- International Joint Research Laboratory for Biointerface and Biodetection, State Key Lab of Food Science and Technology, School of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu, 214122, P.R. China.
- Institute for New Energy Materials and Low Carbon Technologies, School of Materials Science and Engineering, Tianjin University of Technology, Tianjin, 300384, P.R. China.
- Department of Neurosurgery, Wuxi Neurosurgical Institute, Jiangnan University, Wuxi, Jiangsu, 214122, P.R. China.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Hao, C., Meng, D., Shi, W., Xu, C., Wang, Q., & Kuang, H. (2025). Chiral Gold Nanostructure Monolayers as SERS Substrates for Ultrasensitive Detection of Enantiomer Biomarkers of Alzheimer's Disease. Angewandte Chemie International Edition, 64(21). https://doi.org/10.1002/anie.202502115
Vancouver
Hao C, Meng D, Shi W, Xu C, Wang Q, Kuang H. Chiral Gold Nanostructure Monolayers as SERS Substrates for Ultrasensitive Detection of Enantiomer Biomarkers of Alzheimer's Disease. Angewandte Chemie International Edition. 2025;64(21). doi:10.1002/anie.202502115
BibTeX
@article{Hao2025,
author = {Hao, Changlong and Meng, Dan and Shi, Wenxiong and Xu, Chuanlai and Wang, Qing and Kuang, Hua},
title = {Chiral Gold Nanostructure Monolayers as SERS Substrates for Ultrasensitive Detection of Enantiomer Biomarkers of Alzheimer's Disease},
journal = {Angewandte Chemie International Edition},
year = {2025},
volume = {64},
number = {21},
doi = {10.1002/anie.202502115}
}
EUVIMED